Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Venous Thrombosis 2Venous Thromboembolism 2Thrombosis 1Small Cell Lung Carcinoma 1Pulmonary Embolism 1Hemorrhage 1Carcinoma, Small Cell 1

Interventions

apixaban 5Enoxaparin 4Dalteparin 4Warfarin 2Rivaroxaban 2Injections 2Heparin, Low-Molecular-Weight 2Aspirin 2salicylhydroxamic acid 1palbociclib 1fluorescein isothiocyanate-keyhole limpet hemocyanin 1enoxaparin sodium 1edoxaban 1bemiparin 1X-Rays 1Tinzaparin 1Technetium Tc 99m Sulfur Colloid 1Simvastatin 1Saline Solution 1Radiotherapy, Conformal 1Physical Therapy Modalities 1Photons 1Phlebotomy 1Paclitaxel 1Observation 1Musculoskeletal Manipulations 1Hydroxyurea 1Heparin 1Fondaparinux 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thrombosis × bemiparin × Clear all
NCT00311896 2012-06-08

Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)

Clinica Universidad de Navarra, Universidad de Navarra

Phase 3 Terminated
402 enrolled

Neoplasms, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡